Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $587.6100 (0.11%) ($587.6100 - $587.6100) on Wed. Jun. 22, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.04% (three month average) | RSI | 28 | Latest Price | $587.6100(0.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1.4% a day on average for past five trading days. | Weekly Trend | REGN declines -4.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(57%) DIA(39%) IWD(36%) IVW(35%) SPLV(35%) | Factors Impacting REGN price | REGN will decline at least -1.02% in a week (0% probabilities). VIXM(-13%) TBT(-11%) UUP(-6%) VXX(-2%) EDOC(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.02% (StdDev 2.04%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $611.62 | 5 Day Moving Average | $575(2.19%) | 10 Day Moving Average | $572.67(2.61%) | 20 Day Moving Average | $611.62(-3.93%) | To recent high | -20.5% | To recent low | 7.3% | Market Cap | $62.304b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |